Molecular Oncology
Volume 2, Issue 2 , Pages 161-163, August 2008

Unlucky number 13? Differential effects of KIT exon 13 mutation in gastrointestinal stromal tumors☆☆☆

  • Jonathan C. Trent

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Sarcoma Medical Oncology, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Suite FC11.3032, Houston, TX 77030, USA. Tel.: +1 713 792 2636; fax: +1 713 794 1934.

Sarcoma Medical Oncology, The University of Texas – M. D. Anderson Cancer Center, Houston, TX, USA

Sarcoma Research Center, The University of Texas – M. D. Anderson Cancer Center, Houston, TX, USA

The University of Texas at Houston MD/PhD Program, Houston, TX, USA

Department of Pathology, The University of Texas – M. D. Anderson Cancer Center, Houston, TX, USA

MOSE-DICAMP, University of Trieste, Italy

Sarcoma Medical Oncology, The University of Texas – M. D. Anderson Cancer Center, Houston, TX, USA

Sarcoma Research Center, The University of Texas – M. D. Anderson Cancer Center, Houston, TX, USA

Department of Pathology and Laboratory Medicine, The University of Texas – M. D. Anderson Cancer Center, Houston, TX, USA

Sarcoma Research Center, The University of Texas – M. D. Anderson Cancer Center, Houston, TX, USA

Department of Pathology, The University of Texas – M. D. Anderson Cancer Center, Houston, TX, USA

Sarcoma Research Center, The University of Texas – M. D. Anderson Cancer Center, Houston, TX, USA

Department of Surgical Oncology, The University of Texas – M. D. Anderson Cancer Center, Houston, TX, USA

Sarcoma Medical Oncology, The University of Texas – M. D. Anderson Cancer Center, Houston, TX, USA

Sarcoma Research Center, The University of Texas – M. D. Anderson Cancer Center, Houston, TX, USA

published online 03 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Funding Source: This work was supported by an institutional Physician-Scientist Award (JCT, AJFL), NIH/NCI grant 1K23CA109060-02 (JCT), The Amschwand Sarcoma Cancer Foundation (JCT), NIH TL1 RR 024147 from the Center of Clinical and Translational Sciences at The University of Texas-Houston Health Science Center (JCM), and NIH/NCI grant K12 CA090891 (JCM). The DNA Sequencing Core Facility is supported by an NCI Cancer Center Support Grant CA-16672.

☆☆ Conflicts of Interest: None to declare.

PII: S1574-7891(08)00061-6

doi:10.1016/j.molonc.2008.05.002

Molecular Oncology
Volume 2, Issue 2 , Pages 161-163, August 2008

Article Tools

* Image Usage & Resolution